ArticlePloS one2012

MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.

Hongping Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.